Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Contraception|March 22, 2025
Effects of estetrol/drospirenone on self-reported physical and emotional premenstrual and menstrual symptoms: Data from the phase 3 clinical trial in the United States and CanadaCéline Bouchard, Johannes Bitzer, Melissa J Chen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|September 24, 2015
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot studyIngrid J M Duijkers, Christine Klipping, Yvette Zimmerman, et al.
Menopause (New York, N.Y.)|May 8, 2020
A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safetyUlysse Gaspard, Mélanie Taziaux, Marie Mawet, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 21, 2024
Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and RussiaJohannes Bitzer, Céline Bouchard, János Zatik, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2003
MMP-2 and MMP-9 synergize in promoting choroidal neovascularizationVincent Lambert, Ben Wielockx, Carine Munaut, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent mannerCatherine Maillard, Maud Jost, Maria Unni Rømer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 20, 2004
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytesVéronique Masson, Laura Rodriguez de la Ballina, Carine Munaut, et al.
Cancer Research|May 19, 2006
Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient miceMaud Jost, Alicia R Folgueras, Françoise Frérart, et al.
Contraception|October 18, 2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trialsMelissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz, et al.
Contraception|August 3, 2022
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trialsJeffrey T Jensen, Andrew M Kaunitz, Sharon L Achilles, et al.
Pageof 3